Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 3, 2015, Pages 275-284

  Fonseca, D M ^a   Wowk, P F ^a,b   Paula, M O ^a   Gembre, A F ^a   Baruffi, M D ^a   Fermino, M L ^a   Turato, W M ^a   Campos, L W ^a   Silva, C L ^a   Ramos, S G ^a   Horn, C ^c   Marchal, G ^d   Arruda, L K ^a   Russo, M ^a   Bonato, V L D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Funda??o Oswaldo Cruz   (Brazil)

^d INSTITUT PASTEUR   (France)

Author keywords

allergen free immunotherapy; CpG oligodeoxynucleotides; experimental allergy; mycobacterial antigens

Indexed keywords

ALLERGEN; DNA; FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; MYCOBACTERIUM ANTIGEN; MYELOID DIFFERENTIATION FACTOR 88;

ADOPTIVE TRANSFER; ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DERMATOPHAGOIDES; DOWN REGULATION; EOSINOPHIL; FEMALE; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; MITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

EID: 84964199648     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12555     Document Type: Article

References (35)

1. Strachan DP,. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-1260.
2. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM,. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275: 77-79.
3. Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002; 8: 625-629.
4. Riffo-Vasquez Y, Spina D, Page C, Tormay P, Singh M, Henderson B, et al. Effect of Mycobacterium tuberculosis chaperonins on bronchial eosinophilia and hyper-responsiveness in a murine model of allergic inflammation. Clin Exp Allergy 2004; 34: 712-719.
5. Christ AP, Rodriguez D, Bortolatto J, Borducchi E, Keller A, Mucida D, et al. Enhancement of Th1 lung immunity induced by recombinant Mycobacterium bovis Bacillus Calmette-Guerin attenuates airway allergic disease. Am J Respir Cell Mol Biol 2010; 43: 243-252.
6. Wieland CW, Knapp S, Florquin S, de Vos AF, Takeda K, Akira S, et al. Non-mannose-capped lipoarabinomannan induces lung inflammation via toll-like receptor 2. Am J Respir Crit Care Med 2004; 170: 1367-1374.
7. Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, Appelmelk B, et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 2003; 197: 7-17.
8. Ferwerda G, Girardin SE, Kullberg BJ, Le Bourhis L, de Jong DJ, Langenberg DM, et al. NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog 2005; 1: 279-285.
9. Post FA, Manca C, Neyrolles O, Ryffel B, Young DB, Kaplan G,. Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro. Infect Immun 2001; 69: 1433-1439.
10. van Eden W, van der Zee R, Prakken B,. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 2005; 5: 318-330.
11. Quintana FJ, Cohen IR,. The HSP60 immune system network. Trends Immunol 2010; 32: 89-95.
12. Aalberse JA, Prakken BJ, Kapitein B,. HSP: bystander antigen in atopic diseases? Front Immunol 2012; 3: 139.
13. Casale TB, Stokes JR,. Immunotherapy: what lies beyond. J Allergy Clin Immunol 2014; 133: 612-619.
14. Fonseca DM, Wowk PF, Paula MO, Campos LW, Gembre AF, Turato WM, et al. Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway. Clin Exp Allergy 2012; 42: 131-143.
15. Fonseca DM, Paula MO, Wowk PF, Campos LW, Gembre AF, Turato WM, et al. IFN-gamma-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN. Immunol Cell Biol 2011; 89: 777-785.
16. Andiappan AK, Puan KJ, Lee B, Nardin A, Poidinger M, Connolly J, et al. Allergic airway diseases in a tropical urban environment are driven by dominant mono-specific sensitization against house dust mites. Allergy 2014; 69: 501-509.
17. Duez C, Tomkinson A, Shultz LD, Bratton DL, Gelfand EW,. Fas deficiency delays the resolution of airway hyperresponsiveness after allergen sensitization and challenge. J Allergy Clin Immunol 2001; 108: 547-556.
18. Tong J, Bandulwala HS, Clay BS, Anders RA, Shilling RA, Balachandran DD, et al. Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma. J Exp Med 2006; 203: 1173-1184.
19. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545-1556.
20. Strasser A, Jost PJ, Nagata S,. The many roles of FAS receptor signaling in the immune system. Immunity 2009; 30: 180-192.
21. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC,. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346-347.
22. Dias-Baruffi M, Zhu H, Cho M, Karmakar S, McEver RP, Cummings RD,. Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis. J Biol Chem 2003; 278: 41282-41293.
23. Elliott JI, Surprenant A, Marelli-Berg FM, Cooper JC, Cassady-Cain RL, Wooding C, et al. Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol 2005; 7: 808-816.
24. Fischer K, Voelkl S, Berger J, Andreesen R, Pomorski T, Mackensen A,. Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8 + T cells. Blood 2006; 108: 4094-4101.
25. Reed SG, Orr MT, Fox CB,. Key roles of adjuvants in modern vaccines. Nat Med 2013; 19: 1597-1608.
26. Zhang J, Saint-Remy JM, Garrod DR, Robinson C,. Comparative enzymology of native and recombinant house dust mite allergen Der p 1. Allergy 2009; 64: 469-477.
27. Pfaar O, Cazan D, Klimek L, Larenas-Linnemann D, Calderon MA,. Adjuvants for immunotherapy. Curr Opin Allergy Clin Immunol 2012; 12: 648-657.
28. Nakagome K, Okunishi K, Imamura M, Harada H, Matsumoto T, Tanaka R, et al. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine. J Immunol 2009; 183: 209-220.
29. Kennedy NJ, Kataoka T, Tschopp J, Budd RC,. Caspase activation is required for T cell proliferation. J Exp Med 1999; 190: 1891-1896.
30. Zhang J, Cado D, Chen A, Kabra NH, Winoto A,. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998; 392: 296-300.
31. Zhang XR, Zhang LY, Devadas S, Li L, Keegan AD, Shi YF,. Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation. Cell Death Differ 2003; 10: 203-210.
32. Rescigno M, Piguet V, Valzasina B, Lens S, Zubler R, French L, et al. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J Exp Med 2000; 192: 1661-1668.
33. Takahashi Y, Nishikawa M, Takakura Y,. Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vector. Front Biosci 2012; 4: 133-141.
34. McNulty S, Colaco CA, Blandford LE, Bailey CR, Baschieri S, Todryk S,. Heat-shock proteins as dendritic cell-targeting vaccines-getting warmer. Immunology 2013; 139: 407-415.
35. Trombone AP, Tobias KR, Ferriani VP, Schuurman J, Aalberse RC, Smith AM, et al. Use of a chimeric ELISA to investigate immunoglobulin E antibody responses to Der p 1 and Der p 2 in mite-allergic patients with asthma, wheezing and/or rhinitis. Clin Exp Allergy 2002; 32: 1323-1328.